FdaApplication

ANDA 211763

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALEMBIC PHARMACEUTICALS LTD
application_typeANDA
approval_date2023-06-02

Products (3)

ProductActive ingredientStrengthDosage form
NADOLOLNADOLOL80MGTABLET;ORAL
NADOLOLNADOLOL20MGTABLET;ORAL
NADOLOLNADOLOL40MGTABLET;ORAL

3 products